Provided by Tiger Fintech (Singapore) Pte. Ltd.

Johnson & Johnson

156.31
+0.40000.26%
Post-market: 156.310.00000.00%16:05 EDT
Volume:9.47M
Turnover:1.48B
Market Cap:376.09B
PE:17.40
High:158.20
Open:158.20
Low:155.02
Close:155.91
Loading ...

GE Healthcare sees tariffs costing $500 million in 2025, then much less next year

Dow Jones
·
1 hour ago

Johnson & Johnson (NYSE:JNJ) Gains FDA Approval For IMAAVY™ To Treat Myasthenia Gravis

Simply Wall St.
·
2 hours ago

J&J Says Wholesale Acquistion Cost or U.S. List Price of Immune Disorder Drug Imaavy Is $12,480 for 1200Mg Vial

THOMSON REUTERS
·
3 hours ago

Johnson & Johnson Gets US FDA Approval for Imaavy

MT Newswires Live
·
Yesterday

Johnson & Johnson Receives FDA Approval For IMAAVY (nipocalimab-aahu)

Reuters
·
Yesterday

Ireland's reliance on foreign multinational taxes grew in 2024

Reuters
·
Yesterday

US FDA approves J&J's immune disorder drug

Reuters
·
Yesterday

Johnson & Johnson Receives FDA Approval for Imaavy™ (Nipocalimab-Aahu), a New Fcrn Blocker Offering Long-Lasting Disease Control in the Broadest Population of People Living With Generalized Myasthenia Gravis (Gmg)

THOMSON REUTERS
·
Yesterday

Johnson & Johnson receives FDA approval for IMAAVY™ (nipocalimab-aahu), a new FcRn blocker offering long-lasting disease control in the broadest population of people living with generalized myasthenia gravis (gMG)

PR Newswire
·
Yesterday

BRIEF-Johnson & Johnson Receives FDA Approval For IMAAVYTM (nipocalimab-aahu)

Reuters
·
Yesterday

Johnson & Johnson Receives FDA Approval for Imaavytm (Nipocalimab-Aahu), a New Fcrn Blocker Offering Long-Lasting Disease Control in the Broadest Population of People Living With Generalized Myasthenia Gravis (Gmg)

THOMSON REUTERS
·
Yesterday

Nanobiotix Announces Presentation of Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer Followed by a Conference Call

GlobeNewswire
·
Yesterday

Trump to tout US investments from Nvidia, J&J, Hyundai, Toyota

Reuters
·
29 Apr

Johnson & Johnson (JNJ): Among the Most Profitable Blue Chip Stocks to Buy Now

Insider Monkey
·
29 Apr

HSBC cuts biotech stocks: Eli Lilly lowered to Reduce

Investing.com
·
28 Apr

Jim Cramer Says Trump Administration Should Intervene in Johnson & Johnson (JNJ) Legal Issues – ‘Where Are Capitalist Instincts Here?’

Insider Monkey
·
28 Apr

BUZZ-Insulet rises after co names new CEO, signals improved rev outlook

Reuters
·
28 Apr

Insulet Appoints Ashley McEvoy President and CEO

Business Wire
·
28 Apr

Johnson & Johnson : HSBC Raises Target Price to $184 From $180

THOMSON REUTERS
·
28 Apr

Johnson & Johnson announces new data from Cohort 2 of Phase 2b SunRISe-1

TIPRANKS
·
28 Apr